The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D009316:National Institutes of Health (U.S.); D012107:Research Design; D014481:United States
D000970:Antineoplastic Agents